{"title":"Novel Strategies on the Horizon for Metastatic Pancreatic Cancer Management","authors":"M. Akce, B. El-Rayes","doi":"10.17925/OHR.2019.15.1.27","DOIUrl":"https://doi.org/10.17925/OHR.2019.15.1.27","url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67597376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immune Checkpoint Inhibitors and Novel Agents in the Treatment of Metastatic Urothelial Cancer—Current Status and Future Perspectives","authors":"P. Grivas","doi":"10.17925/ohr.2019.15.2.68","DOIUrl":"https://doi.org/10.17925/ohr.2019.15.2.68","url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67597608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Emerging Targeted and Immunotherapies in Cholangiocarcinoma","authors":"Shiraj Sen, R. Shroff","doi":"10.17925/ohr.2019.15.2.71","DOIUrl":"https://doi.org/10.17925/ohr.2019.15.2.71","url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67597648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Genetic Segmentation and Targeted Therapeutics for Multiple Myeloma","authors":"Louis Williams, Beatrix Razzo, J. Caro, G. Morgan","doi":"10.17925/ohr.2019.15.2.87","DOIUrl":"https://doi.org/10.17925/ohr.2019.15.2.87","url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67597322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PARP Inhibitors may be Beneficial in a Broader Range of Patients","authors":"W. Kraus, H. Cecil","doi":"10.17925/ohr.2019.15.2.66","DOIUrl":"https://doi.org/10.17925/ohr.2019.15.2.66","url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67597572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bone Health in Patients with Breast Cancer","authors":"Panagiota Andreopoulou","doi":"10.17925/OHR.2019.15.1.16","DOIUrl":"https://doi.org/10.17925/OHR.2019.15.1.16","url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67597687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Circulating Tumor DNA in Colorectal Cancer—From Concept to Clinic","authors":"M. Loft, A. Jalali, P. Gibbs, J. Tie, Walter","doi":"10.17925/OHR.2019.15.1.33","DOIUrl":"https://doi.org/10.17925/OHR.2019.15.1.33","url":null,"abstract":"<p />","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67597395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ian R Kleckner, Richard F Dunne, Matthew Asare, Calvin Cole, Fergal Fleming, Chunkit Fung, Po-Ju Lin, Karen M Mustian
{"title":"Exercise for Toxicity Management in Cancer-A Narrative Review.","authors":"Ian R Kleckner, Richard F Dunne, Matthew Asare, Calvin Cole, Fergal Fleming, Chunkit Fung, Po-Ju Lin, Karen M Mustian","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although the treatment of cancer is more effective now than ever, patients with cancer still face acute and chronic toxicities such as fatigue, cardiotoxicity, pain, cognitive impairment, and neurotoxicity. In this narrative review, we briefly discuss the use of exercise for toxicity management in patients with cancer, biological mechanisms underlying the toxicities and the effects of exercise, barriers that patients- especially underserved patients-face in adopting and adhering to exercise programs, and new technologies to overcome barriers to exercise. Our conclusions and clinical suggestions are: (1) exercise is safe and effective for treating many toxicities; (2) patients can benefit from a variety of exercise modalities (e.g., walking, cycling, resistance bands, yoga); (3) exercise should be started as soon as possible, even before treatments begin; (4) exercise should be continued as long as possible, as a lifestyle; and (5) barriers to exercise should be identified and addressed, (e.g., continually encouraging patients to exercise, using mobile technology, advocating for safe communities that encourage active lifestyles). Future research should inform definitive clinical guidelines for the use of exercise to ameliorate toxicities from cancer and its treatment.</p>","PeriodicalId":87332,"journal":{"name":"Oncology & hematology review","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922767/pdf/nihms946348.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36059025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
